| Prev Close: | 8.04 |
|---|---|
| Open: | 8.06 |
| Bid: | 7.99 x 1300 |
| Ask: | 8.00 x 1900 |
| 1y Target Est: | 12.44 |
| Beta: | 3.43 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 7.91 - 8.26 |
|---|---|
| 52wk Range: | 1.55 - 9.98 |
| Volume: | 1,408,256 |
| Avg Vol (3m): | 2,982,590 |
| Market Cap: | 646.47M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.21 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Is Keryx Biopharmaceuticals Burning Too Much Cash?at Motley Fool(Sun May 19)
- KERYX BIOPHARMACEUTICALS INC FinancialsEDGAR Online Financials(Wed May 15)
- Earnings Volatility Drives These Stocks in a New Directionat Wall St. Cheat Sheet(Sun May 12)
- Weekly Stock Watch - Week Of May 13, 2013at Seeking Alpha(Sat May 11)
- Short Interest Increases 10% For KERXat TheStreet(Fri May 10)
- Keryx Biopharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed May 8)
- 3 Key Takeaways From Keryx's Earnings Reportat Motley Fool(Wed May 8)
- KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed May 8)
- Keryx: A Small Biotech With Many Catalystsat Seeking Alpha(Wed May 8)
- Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET todayCCBN(Wed May 8)
- Keryx Biopharmaceuticals Earnings: Here’s Why Shares are Up Nowat Wall St. Cheat Sheet(Tue May 7)
- Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial ResultsPR Newswire(Tue May 7)
- Whisper Number Impact: Earnings Preview For Keryx Biopharmaceuticalsat Seeking Alpha(Tue May 7)
- KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Tue May 7)
- Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial ResultsPR Newswire(Mon May 6)
Press Releases
- GSK, AZN, KERX, and RPTP Early Briefing and ReviewAccesswire(Thu May 2)
- Traders Favorite: Keryx Biopharmaceuticals, McDonald's Corporation, Merck & Co, Hertz Global HoldingsAccesswire(Mon Apr 22)
- Radian Group Inc. And Keryx Biopharmaceuticals News: (NYSE: RDN), (NASDAQ; KERX)Accesswire(Mon Apr 22)
Must Read
- Special K churning out new products as part of shift into a weight management toolThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Shares grind higher, yen rebounds on minister's remarksReuters(1969-12-31T18:59:59GMT-05:00)
- Chesapeake Energy hires Anadarko executive as CEOReuters(1969-12-31T18:59:59GMT-05:00)
- Despite talk of Fed changing tack, investors have so far refrained from big profit-takingThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- 2 men arrested in killing of Las Vegas teen who refused to give up his iPadThe Canadian Press(1969-12-31T18:59:59GMT-05:00)